Sat.Aug 08, 2020 - Fri.Aug 14, 2020

article thumbnail

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’

pharmaphorum

Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The data mining tool will be used to try to unearth some of the many unknowns with the virus, using next-generation sequencing (NGS) to see how the genome of SARS-CoV-2 changes over time, along with patient genetic information, results of lung and CT scans,

Vaccines 136
article thumbnail

Potential HIV cure Phase I trial gets FDA green light

Outsourcing Pharma

American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.

FDA 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Happens When 3rd-Party Cookies Expire?

Pharma Marketing Network

2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement. For decades, the third-party cookie has been a core component of any digital marketing strategy, allowing advertisers to deliver targeted ads and measure their effectiveness. However, with increased consumer privacy concerns and regulations, third-party cookies are set to expire by 2022.

98
article thumbnail

12 facts you must know – FLU SEASON 2020/2021

Druggist

With just one month to go, flu season 2020/2021 is just around the corner. It is expected to be that demand for flu vaccination service will be high this year. NHS England has an ambitious target for the uptake in eligible patients groups of at least 75%. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Finding resilience after an HIV diagnosis

pharmaphorum

Author and journalist John-Manuel Andriote has spent much of his career writing about the impact of HIV/AIDS – a job that became much more personal when he himself was diagnosed in 2005. He tells pharmaphorum about the importance of resilience in coping with a serious illness. John first began writing about HIV/AIDS as a journalist in 1986. “I had two friends of mine in their 20s die from AIDS while I was in journalism school in 1985 – a time when AIDS was always in the news and there was a lot

128
128
article thumbnail

PRA: get ready for the RACE Act

Outsourcing Pharma

Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.

105
105

More Trending

article thumbnail

10 fact you must know – FLU SEASON 2020/2021

Druggist

With just one month to go, flu season 2020/2021 is just around the corner. It is expected to be that demand for flu vaccination service will be high this year. NHS England has an ambitious target for the uptake in eligible patients groups of at least 75%. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64.

article thumbnail

Bad behaviour: why understanding human behaviour can improve outcomes

pharmaphorum

Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour. Only ten minutes before I had a mental argument with myself, which I thought I had won, promising not to eat another one until tomorrow. The process that goes on inside our heads, affecting the good and bad choices we make regarding our health every day, is the focus of health psychology and the growing interest around behavioural change.

article thumbnail

Reify Health raises $30m for clinical trial tech

Outsourcing Pharma

The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam.

72
article thumbnail

What Happens When 3rd-Party Cookies Expire?

Pharma Marketing Network

2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement. For decades, the third-party cookie has been a core component of any digital marketing strategy, allowing advertisers to deliver targeted ads and measure their effectiveness. However, with increased consumer privacy concerns and regulations, third-party cookies are set to expire by 2022.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Species-specific Demands Trigger New R&D Areas in Animal Healthcare Market, Notices a New FMI Study

Pharma Mirror

Animal feed represents the most profitable product type segment, presenting multiple investment opportunities for animal healthcare market operators. Top selling potential of animal feed additives is attributed to a growing focus on disease outbreak prevention rather than on curing disease afflicted animals. Animal healthcare market in China and Japan is especially observing robust demand growth.

52
article thumbnail

Digital depression therapy offers hope during COVID-19 pandemic

pharmaphorum

A new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset and therapy app that claims to have similar beneficial effects to drugs but with fewer side-effects. Flow is the first drug-free at-home treatment of its type to be approved in the EU and UK. While using the Flow headset, patients engaged with a therapy app program, which offers personalised behavioural therapy in areas proven to reduce symptoms of depression, including nutrition,

117
117
article thumbnail

Current FDA COVID-19 news

Outsourcing Pharma

The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.

FDA 64
article thumbnail

A Practical Guide to Personalization

Pharma Marketing Network

Great digital should be personal. As the Covid-19 environment continues to cause brands to shift more heavily toward digital and increase their non-physical tactics, it is important to remember this. We must work hard to keep these interactions personal. Personalization of content, experiences, and support services is already a mainstay of ecommerce and retail.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma

Pharma Mirror

QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable.

52
article thumbnail

UK’s second go at a contact tracing app heads for pilot study

pharmaphorum

After ditching its home-grown attempt at a coronavirus contact-tracing app for smartphones, the UK is ready to start pilot trials of a second version based on a platform developed by Apple and Google. The new NHS Test and Trace app is intended to be used as an add-on to the controversial national and local contact-tracing service, and was due to start initial trials yesterday on the Isle of Wight and among a group of NHS volunteers.

116
116
article thumbnail

Trials can overcome COVID-created challenges: Medidata

Outsourcing Pharma

A leader from the clinical research solutions provider discusses the ways pandemic has shaken the trial industry, and how to tackle the obstacles.

52
article thumbnail

To Use DOACs in Obesity or Not?

Med Ed 101

Direct-acting oral anticoagulants (DOACs; also called NOACs – novel oral anticoagulants) are an increasingly popular alternative to warfarin. Meanwhile, the number of obese patients requiring anticoagulation is also increasing. Because the landmark studies that established safety and efficacy for these agents specifically excluded patients with BMI ?

40
article thumbnail

Evidence of positive impact of pharmacists on patient safety published by FIP

Pharma Mirror

The positive impacts of pharmacists in supporting medication without harm are described in a new publication from the International Pharmaceutical Federation (FIP) released today. The World Health Organization reports that one in four patients is harmed by the care they receive in primary and ambulatory care settings, including harm from medicines. It estimates the global.

52
article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic in better shape than ever. These are the brands that have clearly demonstrated emotional intelligence, that have shown emotional empathy to their target audience. They understand the current, heightened emotional state of their customers and respond to it in ways that show they give a damn.

article thumbnail

Integrated platform targets trial performance

Outsourcing Pharma

A partnership between two trial tech providers aims to create a more powerful, efficient and effective study solution for sites, sponsors and CROs.

52
article thumbnail

Mirtazapine For Insomnia – Are You Using It Correctly?

Med Ed 101

Mirtazapine is commonly used in elderly patients with depression who are also suffering from insomnia. Mirtazapine is often chosen because it is much safer than benzodiazepines, “z-drugs”, and antipsychotics. The mechanisms of mirtazapine (podcast episode on the pharmacology) include the release of norepinephrine via presynaptic adrenergic auto-receptor blockade, increased serotonin production through stimulation of adrenoreceptors […].

40
article thumbnail

What Exactly Is Tadalafil?

Pharma Mirror

Tadalafil is a prescription drug well-known to men over the age of 40 who usually have to deal with episodic or permanent erectile dysfunction. Yet there’s more to this substance than its typical use in managing impotence by improving the blood flow to the genitals. The substance is used in many other treatments and has. The post What Exactly Is Tadalafil?

52
article thumbnail

Verona Pharma to trial lung drug ensifentrine for COVID-19

pharmaphorum

Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug companies repurposing their medicines to fight the pandemic. Based in the UK and US, Verona is due to start a phase 3 trial of ensifentrine in chronic obstructive pulmonary disease (COPD) later this year after encouraging results in phase 2.

article thumbnail

American Gastroenterological Association opts for virtual trial kit

Outsourcing Pharma

The medical organization has selected Rx.Health's TrialEngage, a set of digital tools geared toward supporting and improving decentralized trials.

52
article thumbnail

Pfizer inks manufacturing deal with Gilead for COVID-19 med remdesivir

Pharma Times

Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment

53
article thumbnail

How Antiarrhythmic Drugs are Used in Cardiac Life Support

Pharma Mirror

One of the most interesting types of cardiovascular pharmaceuticals around is antiarrhythmic drugs, which can change the way your heartbeats. Antiarrhythmic drugs help counteract abnormal heart rhythms resulting from the irregular electrical activity. These could include atrial fibrillation, atrial flutter, supraventricular tachycardia, and Wolff-Parkinson-White syndrome, among others.

52
article thumbnail

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

pharmaphorum

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. Though Novo Nordisk is perhaps not as much of a household name as other pharma companies in the UK, it has a huge presence in diabetes, with a bigger market cap than the likes of GSK and AstraZeneca – and UK GM Pinder Sahota is keen to shout about the organisation that he describes as a “slee

Packaging 111
article thumbnail

Eversana partners on research data assessment

Outsourcing Pharma

The company is joining with ICER to help promote use of robust, repeatable indirect comparisons in health tech assessments.

57
article thumbnail

FDA accepts application for self-administered Xolair use

Pharma Times

If approved drug would offer a more flexible option for patients

FDA 58
article thumbnail

Medical Face Shield Sales Can Soar Dramatically as Airborne Transmission Become a Real Threat

Pharma Mirror

Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights, medical face shields market will grow at over 11% CAGR through 2030. Medical face shields prove to be an effective means for first line protection against.

52
article thumbnail

BMS’ Opdivo aces trial in asbestos-linked lung cancer

pharmaphorum

Bristol-Myers Squibb’s Opdivo has improved survival in a trial involving patients with mesothelioma, a form of lung cancer, getting one up over rival checkpoint inhibitor Keytruda from Merck & Co. The results of the CheckMate-743 trial showed that a combination of Opdivo (nivolumab) with low-dose Yervoy (ipilimumab) reduced the risk of death by 26% compared to platinum-based chemotherapy after 22 months of follow-up.

article thumbnail

Grand River Aseptic Manufacturing tackles unique expansion

Outsourcing Pharma

When growing market demand moved the Michigan CDMO to expand, it opted for a novel design-construction approach to building bigger digs.

52
article thumbnail

AstraZeneca ships first doses of flu vaccine

Pharma Times

Company will manufacture over 25% more doses than previously planned